Inhibrx Biosciences Inc
Inhibrx Biosciences Inc (INBX) Option Chain
As of September 22, 2026, Inhibrx Biosciences Inc is trading at $110.67, a -1.23% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 87.8%. IV Rank is 19%.
Read more
Tracking the INBX option chain helps you see every strike and expiry on Inhibrx Biosciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Inhibrx Biosciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of INBX options activity at a glance. Use our scanner to monitor the INBX option chain in real time and filter for the INBX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For INBX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the INBX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where INBX stock options are being actively traded and where they are not.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma.
The company was incorporated in 2024 and is based in La Jolla, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Inhibrx Biosciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen INBX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of INBX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile25.79% Subdued
- Market cap (M$)1,629
- 52 weeks high-28.73%
- 52 weeks low308.08%
- Analyst recommendationStrong Buy
1.50 - Target price$266.67
140.96% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-13
- P/E—
- Future P/E—
- EPS (ttm)-8.88
- EPS growth next 5 years15.68%
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 36.20 | 0 | 0 | 5.48 | 10.67 | 12.30 | 20.00 | 100.00 | -9.64 | 2.70 | 5.50 | 0.00 | 4.10 | 3 | 9 | 63.80 |
| 44.64 | 0 | 0 | 7.98 | 5.67 | 10.30 | 17.00 | 105.00 | -5.12 | 2.00 | 10.00 | 0.00 | 6.00 | 0 | 0 | 55.36 |
| 52.91 | 20 | 0 | 10.33 | 0.67 | 8.00 | 14.00 | 110.00 | -0.61 | 5.00 | 11.60 | 0.00 | 8.30 | 1 | 35 | 47.09 |
| 60.71 | 20 | 0 | 9.00 | 0.00 | 6.00 | 12.00 | 115.00 | +3.91 | 7.00 | 14.20 | 4.33 | 6.27 | 0 | 0 | 39.29 |
| 67.80 | 143 | 0 | 7.50 | 0.00 | 4.00 | 11.00 | 120.00 | +8.43 | 11.00 | 18.90 | 9.33 | 5.62 | 0 | 0 | 32.20 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full INBX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→